HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Teenager, 19, stabbed in Crumlin area of Dublin, reports

Gardai make renewed appeal for information relating to death of man in Swords

1,000 km of Victorian piping needs to be replaced at cost of €13bn: Irish Water

18 year old dies in motorcycling accident in Dublin


Today's Stories

Ian Bailey: ‘Order is an abuse of process’

Páirc Uí Chaoimh games faced injunction over traffic chaos fears

Mary Lou McDonald backs Gerry Adams to remain at summit of Sinn Féin

Martens’ 911 call ‘distinctly calm’

Lifestyle

Three great routes for summer scrambling fans

Read the terms when it comes to car finance

Back to Ballybeg with the Mundy sisters

Wife, mother, and maker of fine furniture

More From The Irish Examiner